To accelerate breakthroughs, the Damon Runyon Foundation provides today's best young scientists with funds to pursue innovative cancer research.
- Today’s Promising Areas of Cancer Research
- What is Cancer?
- A Broken Pipeline?
A Generation of Science at Risk
- ARISE Report
Early Career Scientists and High-Risk, High Reward Research - American Academy of Arts and Sciences
- Why We’re Losing the War on Cancer (And How To Win It)
Clifton Leaf - Fortune Magazine
September 19, 2006
Karla A. Kirkegaard, PhD (Damon Runyon Fellow '83-'85), Professor and Chair of Microbiology and Immunology at Stanford University School of Medicine, Stanford, has been selected to receive the Pioneer Award by the Director of the National Institutes of Health. The award supports exceptionally creative scientists who take innovative approaches to major challenges in biomedical research. Dr. Kirkegaard will use the $2.5 million, 5-year award to further her work identifying and validating targets for antiviral drugs to fight drug-resistant variants of dengue, West Nile, hepatitis C, and polio viruses.